[1] Herold C, Heinz R, Niedobitek G, et al. Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and C[J]. Liver, 2001, 21(4): 260-265.
[2] Giannini E, Fasoli A, Chiarbonello B, et al.13C-aminopy-rine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection[J]. Aliment Pharmacol Ther, 2002, 16(4): 717-725.
[3] Herold C, Berg P, Kupfal D, et al. Parameters of microsomal and cytosolic liver function but not of liver perfusion predict portal vein velocity in noncirrhotic patients withchronic hepatitis C[J]. Dig Dis Sci, 2000, 45(11): 2233-2237.
[4] Herold C, Heinz R, Raderspiel-Troger M, et al. Quantitative testing of liver function in patients with cirrhosis due to chronic hepatitis C to assess disease severity[J]. Liver,2001,21(1): 26-30.
[5] Herold C, Ganslmayer M, Ocker M, et al. Inducibility of microsomal liver function may differentiate cirrhotic patients with maintained compared with severely compromised liver reserve[J]. J Gastroenterol Hepato, 2003, 18(4): 445-449.
[6] Wensing G, Lotterer E, Link I, et al. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function-]. Hepatology, 1997, 26(5): 1149-1155.
[7] Lotterer E, Hogel J, Gaus W, et al. Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: a retrospective feasibility study[J]. Hepatology, 1997, 26(6): 1426-1433.
[8] Heideche CD, Martin WG, Muller DF, et al. Acute liver allograft rejection and liver function: quantitative evaluation using the[14C] aminopyrine breath test[J]. Transplant Proc, 1993,254): 2640-2641.
[9] Caubet MS, Laplante A, Caille J, et al.[13C] aminopyrine and[13C] caffeine breath test: influence of gender, cigarette smoking and oral contraceptives intake[J]. Isotopes Environ Health Stud, 2002, 38(2): 71-77.